These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8749021)

  • 21. Specificity of lipid transfer protein for molecular species of cholesteryl ester.
    Morton RE
    J Lipid Res; 1986 May; 27(5):523-9. PubMed ID: 3734635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesteryl ester transfer protein promotes the association of HDL apolipoproteins A-I and A-II with LDL: potentiation by oleic acid.
    Lagrost L; Barter PJ
    Biochim Biophys Acta; 1992 Aug; 1127(3):255-62. PubMed ID: 1511003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Function of cholesteryl ester transfer protein in reverse cholesterol transport.
    McPherson R
    CMAJ; 1993 Jun; 148(12):2165-6. PubMed ID: 8324692
    [No Abstract]   [Full Text] [Related]  

  • 24. Establishment of anti-human cholesteryl ester transfer protein monoclonal antibodies and radioimmunoassaying of the level of cholesteryl ester transfer protein in human plasma.
    Fukasawa M; Arai H; Inoue K
    J Biochem; 1992 Jun; 111(6):696-8. PubMed ID: 1500412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous transfer of cholesteryl ester and phospholipid by protein(s) isolated from human lipoprotein-free plasma.
    Ihm J; Harmony JA; Ellsworth J; Jackson RL
    Biochem Biophys Res Commun; 1980 Apr; 93(4):1114-20. PubMed ID: 7396900
    [No Abstract]   [Full Text] [Related]  

  • 26. Stereospecific inhibition of CETP by chiral N,N-disubstituted trifluoro-3-amino-2-propanols.
    Connolly DT; Witherbee BJ; Melton MA; Durley RC; Grapperhaus ML; McKinnis BR; Vernier WF; Babler MA; Shieh JJ; Smith ME; Sikorski JA
    Biochemistry; 2000 Nov; 39(45):13870-9. PubMed ID: 11076528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cholesteryl ester transfer protein by apolipoproteins, lipopolysaccharides, and cholesteryl sulfate.
    Connolly DT; Krul ES; Heuvelman D; Glenn KC
    Biochim Biophys Acta; 1996 Nov; 1304(2):145-60. PubMed ID: 8954138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesteryl ester transfer protein: friend or foe?
    Fielding CJ; Havel RJ
    J Clin Invest; 1996 Jun; 97(12):2687-8. PubMed ID: 8675675
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of spherical reconstituted high density lipoprotein for the measurement of cholesteryl ester transfer protein activity in human plasma.
    Stone MA; Lenaghan C; Torr NC; Torkington T; Wood KE; Carey F
    Biochem Soc Trans; 1995 Aug; 23(3):491S. PubMed ID: 8566391
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholesteryl ester transfer protein inhibition: effect on reverse cholesterol transport?
    Rensen PC; Havekes LM
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):681-4. PubMed ID: 16556861
    [No Abstract]   [Full Text] [Related]  

  • 31. Modulation of the activity of the human cholesteryl ester transfer protein by carboxylated derivatives. Evidence for 13-cis-retinoic acid as a potent activator of the protein's activity in plasma.
    Florentin E; Athias A; Lagrost L
    Eur J Biochem; 1996 Sep; 240(3):699-706. PubMed ID: 8856073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cholesterol ester transfer protein (CETP)].
    Bujo H; Saito Y
    Nihon Rinsho; 1990 Nov; 48(11):2492-7. PubMed ID: 2270013
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins.
    Lie J; de Crom R; Jauhiainen M; van Gent T; van Haperen R; Scheek L; Jansen H; Ehnholm C; van Tol A
    Biochem J; 2001 Dec; 360(Pt 2):379-85. PubMed ID: 11716766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma lipoproteins from patients with poorly controlled diabetes mellitus and "in vitro" glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo-B-containing lipoproteins.
    Passarelli M; Catanozi S; Nakandakare ER; Rocha JC; Morton RE; Shimabukuro AF; Quintão EC
    Diabetologia; 1997 Sep; 40(9):1085-93. PubMed ID: 9300246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.
    Tall A; Sammett D; Granot E
    J Clin Invest; 1986 Apr; 77(4):1163-72. PubMed ID: 3958185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver.
    Gauthier A; Lau P; Zha X; Milne R; McPherson R
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2177-84. PubMed ID: 16123327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Putative role of cholesteryl ester transfer protein in removal of cholesteryl ester from vascular interstitium, studied in a model system in cell culture.
    Stein Y; Stein O; Olivecrona T; Halperin G
    Biochim Biophys Acta; 1985 May; 834(3):336-45. PubMed ID: 3995071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
    Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
    J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
    Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
    Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Very high density lipoproteins induced by plasma cholesteryl ester transfer protein (CETP) have a potent antiatherogenic function.
    Yamashita S; Ishigami M; Arai T; Sakai N; Hirano K; Kameda-Takemura K; Tokunaga K; Matsuzawa Y
    Ann N Y Acad Sci; 1995 Jan; 748():606-8. PubMed ID: 7695214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.